Selective vulnerability of GABAergic neurons in chronic migraine

Kazi Helal Hossain, Timothy Chuong, Emily Abad, Justin Lin, Chenchen Xia, Meng Li, Yibu Chen, Xianghong Arakaki, Anju VasudevanThe Journal of Headache and Pain 2025 · DOI

TL;DR

This study reveals that chronic migraine in male mice involves a selective loss and dysfunction of GABAergic neurons in key brain regions, accompanied by increased neuronal activation and stress responses. This male-specific vulnerability suggests distinct underlying mechanisms compared to females, underscoring the need for sex-specific approaches in migraine research and treatment.

What Problem Does This Paper Address?

Migraine is a debilitating neurological disorder with a significant genetic component, yet its precise pathophysiological mechanisms, especially in chronic forms, remain incompletely understood. While GABAergic neurons, the brain's primary inhibitory system, are known to play a role in pain processing and psychiatric disorders, their specific involvement in chronic migraine is unclear. Previous research has hinted at altered GABAergic signaling, but findings have been inconsistent, and a critical gap exists in understanding potential sex-specific differences in these mechanisms. This paper aims to elucidate the role of GABAergic neurons in chronic migraine, specifically investigating whether there are sex-dependent alterations in these inhibitory circuits.

Methods

The researchers utilized a rodent model of chronic migraine induced by repeated injections of nitroglycerin (NTG), a known migraine trigger.

  • Chronic Migraine Model: Adult male and female GAD65-GFP transgenic mice (which express green fluorescent protein in GABAergic neurons) were administered NTG (10 mg/kg) or saline (control) every other day for nine days. This regimen was shown to induce basal hypersensitivity, mimicking chronic migraine.
  • Behavioral Assessment: Mechanical hypersensitivity, a hallmark of migraine-associated allodynia, was measured using von Frey filaments before and after NTG administration.
  • Immunohistochemistry: Brain tissue from key regions (neocortex, hippocampus, amygdala, locus coeruleus) was analyzed for:
  • GABAergic neuron presence: Using GFP fluorescence in GAD65-GFP mice.
  • Neuronal activation: By assessing the expression of ΔFosB, a marker of sustained neuronal activation.
  • Apoptosis: By quantifying active caspase-3 staining, indicating programmed cell death.
  • Stress-related neuropeptides: Examining the expression of PACAP and its receptor PAC1.
  • Neurotrophic factors: Investigating BDNF and its receptor TRK1B.
  • Gene Expression Analysis (Rats): In a separate rat model, RNA sequencing (RNA-seq) was performed on choroid plexus tissue to analyze differential gene expression, focusing on GABA signaling pathways and chloride homeostasis regulators (NKCC1, KCC2).
  • Statistical Analysis: Standard statistical tests (Student's t-test, Mann-Whitney U test) were used, with corrections for multiple comparisons where appropriate. Linear mixed-effects models were employed for region-specific analyses.

Datasets

Not discussed in the paper. The study relies on experimental data generated from animal models.

Key Insights and Ideas

  • Male-Specific GABAergic Neuron Vulnerability: The most striking finding is the selective loss and apparent dysfunction of GABAergic neurons in specific brain regions (neocortex, hippocampus, amygdala, locus coeruleus) in male mice subjected to the chronic migraine model. Females, despite exhibiting similar behavioral hypersensitivity, did not show these GABAergic alterations.
  • Neuronal Stress and Apoptosis: The loss of GABAergic neurons in males was accompanied by increased expression of ΔFosB (indicating sustained neuronal activation) and active caspase-3 (indicating apoptosis), suggesting that these neurons are undergoing stress and programmed cell death.
  • Upregulation of Stress Pathways: Male chronic migraine mice showed increased expression of stress-related neuropeptides like PACAP and its receptor PAC1, along with downstream targets BDNF and TRK1B. This suggests a heightened stress response in these animals.
  • Choroid Plexus Dysregulation (Sex-Specific): In the choroid plexus, gene expression analysis revealed opposite regulation of GABA signaling pathways between sexes. Males showed inhibition of GABA signaling, while females showed activation. Crucially, males exhibited increased NKCC1 expression, suggesting a disruption in chloride homeostasis that could impair GABAergic inhibition.
  • Implications for Therapeutic Development: The sex-specific nature of these findings strongly suggests that current migraine treatments, which may not account for these differences, could be less effective or have different side effects in males versus females.

Key Results

  • GABAergic Neuron Loss: NTG-treated male mice showed a significant reduction in GABAergic neurons in the neocortex, hippocampus, amygdala, and locus coeruleus compared to saline-treated controls (P < 0.0001). No such reduction was observed in female mice.
  • Increased Neuronal Activation: ΔFosB expression was significantly increased in the same brain regions in NTG-treated male mice (P < 0.0001).
  • Increased Apoptosis: Active caspase-3 staining was significantly elevated in GABAergic neurons in NTG-treated male mice across all four brain regions examined (P < 0.0012 to P < 0.0001).
  • Stress Peptide Upregulation: PACAP and PAC1 expression were significantly increased in NTG-treated male mice in all four brain regions (P < 0.0001).
  • Neurotrophic Factor Upregulation: BDNF and TRK1B expression were significantly increased in NTG-treated male mice in all four brain regions (P < 0.0001).
  • Choroid Plexus Gene Expression: IPA analysis indicated inhibition of GABA signaling in male rat choroid plexus and activation in female rat choroid plexus. NKCC1 expression was significantly increased in NTG-treated male rats (P < 0.0001), while KCC2 expression remained unchanged.

Limitations and Future Work

  • Focus on Males: While the study highlights sex-specific differences, the primary focus was on male vulnerability. Future research should delve deeper into the specific mechanisms underlying the lack of GABAergic neuron loss in females, exploring alternative pathways such as enhanced parasympathetic regulation or distinct neuroimmune mechanisms.
  • Limited Brain Regions: The analysis was restricted to four brain regions. Further studies should map the extent of GABAergic disruption across the entire brain to define the full scope of inhibitory circuit involvement.
  • Model Specificity: The study used the NTG model. Future work should investigate whether these findings generalize to other migraine paradigms, such as CGRP-based or genetic models.
  • Human Corroboration: The study acknowledges the absence of direct evidence of apoptosis in human male chronic migraine brains. Future research should aim to correlate these animal findings with human clinical data.
  • Therapeutic Implications: The authors emphasize the need for sex-specific therapeutic strategies, suggesting that targeting the identified male-specific vulnerabilities could lead to more effective and personalized treatments for chronic migraine.

Summary updated

Abstract

These findings reveal a male-specific vulnerability of GABAergic neurons in chronic migraine and suggest a sex-dependent divergence in the underlying pathophysiological mechanisms. This highlights the critical need for sex-specific approaches to migraine research and therapeutic development.
BibTeX
@article{hossain2025selective,
  author = {Kazi Helal Hossain and Timothy Chuong and Emily Abad and Justin Lin and Chenchen Xia and Meng Li and Yibu Chen and Xianghong Arakaki and Anju Vasudevan},
  title = {{Selective vulnerability of GABAergic neurons in chronic migraine}},
  journal = {The Journal of Headache and Pain},
  year = {2025},
  doi = {10.1186/s10194-025-02223-9},
}
Figure